AlphaQuest LLC Sells 106,355 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

AlphaQuest LLC cut its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 96.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,477 shares of the medical instruments supplier's stock after selling 106,355 shares during the quarter. AlphaQuest LLC's holdings in DENTSPLY SIRONA were worth $66,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Nordea Investment Management AB increased its stake in DENTSPLY SIRONA by 245.0% during the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier's stock worth $4,754,000 after purchasing an additional 178,639 shares in the last quarter. JPMorgan Chase & Co. increased its stake in DENTSPLY SIRONA by 206.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after purchasing an additional 1,244,326 shares in the last quarter. Bank of New York Mellon Corp increased its stake in DENTSPLY SIRONA by 27.9% during the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock worth $45,611,000 after purchasing an additional 523,692 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in DENTSPLY SIRONA by 1.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock worth $39,880,000 after purchasing an additional 35,360 shares in the last quarter. Finally, Barclays PLC increased its stake in DENTSPLY SIRONA by 21.8% during the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock worth $8,301,000 after purchasing an additional 54,920 shares in the last quarter. 95.70% of the stock is owned by institutional investors.

Remove Ads

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock traded down $0.04 during trading on Friday, hitting $15.56. 12,658,219 shares of the stock were exchanged, compared to its average volume of 2,998,767. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company has a fifty day moving average price of $17.92 and a 200-day moving average price of $20.50. The stock has a market capitalization of $3.10 billion, a price-to-earnings ratio of -7.52, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 1-year low of $14.78 and a 1-year high of $33.42.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.11%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.07%.

Insider Buying and Selling at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were acquired at an average cost of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares of the company's stock, valued at $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.52% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on XRAY. Robert W. Baird lowered their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. Barrington Research lowered their target price on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. Morgan Stanley reduced their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a research report on Tuesday, December 17th. Mizuho cut their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Thursday, March 13th. Finally, Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Twelve analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA has a consensus rating of "Hold" and a consensus price target of $23.33.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.